drugset / Trial / NCT01124344
Safety and Pharmacology Study of BMS-866949
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to determine whether multiple doses.of BMS-886949 are safe and tolerable
Timeline
- Start
- 2010-05
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-866949 | Unknown | 3 mg | Oral |
| Comparator | BMS-866949 | Unknown | 10 mg | Oral |
| Comparator | BMS-866949 | Unknown | 30 mg | Oral |
| Comparator | BMS-866949 | Unknown | 45 mg | Oral |
| Comparator | BMS-866949 | Unknown | 60 mg | Oral |
| Comparator | BMS-866949 | Unknown | 90 mg | Oral |